Clinical Response to Adalimumab Therapy is Associated with Increased Fecal Short Chain Fatty Acids in Hidradenitis Suppurativa

Published: 3 November 2021| Version 1 | DOI: 10.17632/36bj7rmsnn.1
Contributor:
John Frew

Description

FASTQ Files for article "Clinical Response to Adalimumab Therapy is Associated with Increased Fecal Short Chain Fatty Acids in Hidradenitis Suppurativa"

Files

Categories

Microbiome, Short Chain Fatty Acid

Licence